 |
|
|
|
Equip T for the vaccination of healthy horses against tetanus.
An opaque, aqueous vaccine for intramuscular injection. Each 2ml of vaccine contains concentrated immunopurified tetanus toxoid (100 Lf units) adsorbed onto aluminium phosphate.
|
|
Presentation
An opaque, aqueous vaccine for intramuscular injection. Each 2ml of vaccine contains concentrated immunopurified tetanus toxoid (100 Lf units) adsorbed onto aluminium phosphate.
Uses
For the vaccination of healthy horses against tetanus.
|
|
Dosage and administration
Dose
2 ml
Administration
Equip T should be shaken before use and administered by deep intramuscular injection.
The primary course consists of two injections, allowing an interval of 4-6 weeks between them. Maximum immunity should be achieved about two weeks after the second vaccination.
A booster dose should be given 36 months after completion of the primary course of vaccination and then repeated at intervals of up to 36 months.
Equip T has been shown to be safe in 3-4 month old foals. However, the efficacy of active immunisation of young foals against tetanus will be influenced by the level of maternally derived antibodies. This will vary between individuals due to a number of factors, e.g. the immune status of the dam; adequacy of colostral intake by the foal, etc. Only when maternally derived antibodies have fallen below protective levels can optimum efficacy of vaccination be assured.
|
|
Contra-indications, warnings, etc
Avoid stress when vaccinating heavily pregnant mares, since it is recognised that there is always an inherent risk in these procedures at this time.
Only healthy horses should be vaccinated.
Horses which have received immuno-suppressive drugs, e.g. glucocorticoids, should not be vaccinated until an interval of at least four weeks has elapsed.
Equip T is highly purified by a specific immunological process which should ensure that reactivity is extremely unlikely. However, as with all vaccines, occasional hypersensitivity reactions may occur.
In the event of an allergic or anaphylactic reaction, immediate treatment should be given with a soluble glucocorticoid intravenously (e.g. betamethasone sodium phosphate) or adrenalin intramuscularly.
A small proportion of animals may exhibit a reaction to vaccination. This may be manifest by a mild, transient rise in temperature, typically 9-12 hours post vaccination, or a small, soft local swelling at the injection site. Both conditions are shown to have resolved the day following vaccination and are considered to be insignificant.
In the event of simultaneous administration of Equip F and Equip T separate injection sites should be used.
When an antiserum and a vaccine are administered simultaneously separate injection sites should be used.
Pharmaceutical precautions
Store between +2° and +8°C. Protect from light. Do not freeze.
|
|
Legal category
POM-V (previously POM).
Packaging Quantities
10×2 ml
Further information
In any animal population there may be a small number of individuals which fail to respond fully to vaccination. Successful vaccination depends upon correct storage and administration of the vaccine together with the animal's ability to respond. This can be influenced by such factors as genetic constitution, intercurrent infection, age, the presence of maternally derived antibodies, nutritional status, concurrent drug therapy and stress.
Marketing authorisation number
Vm 00201/4208.
|
|
|
